Comparative Evaluation of [ 18 F]5-Fluoroaminosuberic Acid and (4 S )-4-3-[ 18 F]fluoropropyl)-l-Glutamate as System –Targeting Radiopharmaceuticals
Journal of Nuclear Medicine · 2023
DOI: 10.2967/jnumed.122.265254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Milena Colovic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Glioblastoma, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
System [Formula: see text] is an appealing biomarker for targeting oxidative stress with oncologic PET imaging and can serve as an alternative PET biomarker to other metabolic indicators. In this paper, we report a direct comparison of 2 18F-labeled amino acid radiopharmaceuticals targeting system [Formula: see text], [18F]5-fluoroaminosuberic acid ([18F]FASu) and (4S)-4-(3-[18F]fluoropropyl)-l-glutamate ([18F]FSPG), in terms of their uptake specificity and ability to image glioma and lung cancer xenografts in vivo.
Methods
Both tracers were synthesized according to previously published procedures. In vitro uptake specificity assays were conducted using prostate (PC-3), glioblastoma (U-87), colorectal (HT-29), ovarian (SKOV3), breast (MDA-MB-231), and lung cancer (A549) cell lines. PET/CT imaging and biodistribution studies were conducted in immunocompromised mice bearing U-87 or A549 xenografts.
Results
In vitro cell uptake assays showed that the tracers accumulated in cancer cells in a time-dependent manner and that the uptake of [18F]FASu was blocked by the system [Formula: see text] inhibitor sulfasalazine and rose bengal, but not by system L inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid, system [Formula: see text] inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid, or l-serine, which is a substrate for transporter systems A, ACS, B0, and B0,+ Conversely, [18F]FSPG uptake decreased significantly in the presence of an excess of L-trans-pyrrolidine-2,4-dicarboxylic acid in 2 of 3 tested cell lines, indicating some reliance on system [Formula: see text] in these cells. In an in vivo setting, [18F]FASu and [18F]FSPG generated good-contrast PET images in U-87 and A549 tumor-bearing mice. Tracer accumulation in A549 tumors was 5.0 ± 0.8 percentage injected dose (%ID)/g ([18F]FASu, n ≥ 5) and 6.3 ± 1.3 %ID/g ([18F]FSPG, n ≥ 6, P = 0.7786), whereas U-87 xenografts demonstrated uptake of 6.1 ± 2.4 %ID/g ([18F]FASu, n ≥ 4) and 11.2 ± 4.1 %ID/g ([18F]FSPG, n ≥ 4, P = 0.0321) at 1 h after injection. Conclusion: [18F]FSPG had greater in vitro uptake than [18F]FASu in all cell lines tested; however, our results indicate that residual uptake differences exist between [18F]FSPG and [18F]FASu, suggesting alternative transporter activity in the cell lines tested. In vivo studies demonstrated the ability of both [18F]FASu and [18F]FSPG to image glioblastoma (U-87) and non-small cell lung cancer (A549) xenografts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada.
- Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
- Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and.
- Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada; pschaffer@triumf.ca.
- Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
Förderung
- CIHR
Zitieren
APA
Colovic, M., Yang, H., Southcott, L., Merkens, H., Colpo, N., Bénard, F., & Schaffer, P. (2023). Comparative Evaluation of [ 18 F]5-Fluoroaminosuberic Acid and (4 S )-4-3-[ 18 F]fluoropropyl)-l-Glutamate as System –Targeting Radiopharmaceuticals. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.265254
Vancouver
Colovic M, Yang H, Southcott L, Merkens H, Colpo N, Bénard F, et al. Comparative Evaluation of [ 18 F]5-Fluoroaminosuberic Acid and (4 S )-4-3-[ 18 F]fluoropropyl)-l-Glutamate as System –Targeting Radiopharmaceuticals. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.265254
BibTeX
@article{Colovic2023,
author = {Colovic, Milena and Yang, Hua and Southcott, Lily and Merkens, Helen and Colpo, Nadine and Bénard, Francois and Schaffer, Paul},
title = {Comparative Evaluation of [ 18 F]5-Fluoroaminosuberic Acid and (4 S )-4-3-[ 18 F]fluoropropyl)-l-Glutamate as System –Targeting Radiopharmaceuticals},
journal = {Journal of Nuclear Medicine},
year = {2023},
doi = {10.2967/jnumed.122.265254}
}
EUVIMED